Cancer incidence and mortality in Europe, 2004, Annals of Oncology, vol.16, issue.3, pp.481-88, 2004. ,
DOI : 10.1093/annonc/mdi098
Multimodality Therapy for Stage III Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.23, issue.14, pp.14-3257, 2005. ,
DOI : 10.1200/JCO.2005.03.008
The value of positron emission tomography (PET) imaging in disease staging and therapy assessment, Annals of Oncology, vol.13, issue.suppl 4, pp.227-261, 2002. ,
DOI : 10.1093/annonc/mdf664
Wahl and others, 'From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors, Journal of Nuclear Medicine, vol.50, issue.1, pp.122-50, 2009. ,
Areas of High 18F-FDG Uptake on Preradiotherapy PET/CT Identify Preferential Sites of Local Relapse After Chemoradiotherapy for Non-Small Cell Lung Cancer, Journal of Nuclear Medicine, vol.56, issue.2, pp.196-203, 2015. ,
DOI : 10.2967/jnumed.114.144253
URL : https://hal.archives-ouvertes.fr/hal-01117241
Prediction of Survival by [18F]fluorodeoxyglucose Positron Emission Tomography in Patients with Locally Advanced Non-Small-Cell Lung Cancer Undergoing Definitive Chemoradiation Therapy: Results of the ACRIN 6668, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, pp.3130-3823, 2013. ,
Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?, Radiotherapy and Oncology, vol.91, issue.3, pp.399-404, 2009. ,
DOI : 10.1016/j.radonc.2009.01.003
A Prognostic Factor for Inoperable Non- Small Cell Lung Cancer, European Journal of Cancer, vol.41, pp.11-1533, 1990. ,
Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project, Journal of Thoracic Oncology, vol.5, issue.5, pp.612-631, 2010. ,
DOI : 10.1097/JTO.0b013e3181d0a4f5
Prognostic Stratification of Stage IIIA-N2 Non-Small-Cell Lung Cancer after Induction Chemotherapy: A Model Based on the Combination of Morphometric- Pathologic Response in Mediastinal Nodes and Primary Tumor Response on Serial ,
Prognostic implications of volume-based measurements on FDG PET/CT in stage III non-small-cell lung cancer after induction chemotherapy, European Journal of Nuclear Medicine and Molecular Imaging, vol.47, issue.5, pp.668-76, 2013. ,
DOI : 10.1007/s00259-012-2321-7
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0, European Journal of Nuclear Medicine and Molecular Imaging, vol.28, issue.10, pp.328-54, 2015. ,
DOI : 10.1007/s00259-014-2961-x
Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project, Journal of Thoracic Oncology, vol.3, issue.1, pp.6-12, 2008. ,
DOI : 10.1097/JTO.0b013e31815e6d6b
Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project, Journal of Thoracic Oncology, vol.5, issue.5, pp.612-631, 2010. ,
DOI : 10.1097/JTO.0b013e3181d0a4f5
F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non???Small Cell Lung Cancer, American Journal of Roentgenology, vol.205, issue.3, pp.623-651, 2015. ,
DOI : 10.2214/AJR.14.13847
Chen and othersPrognostic Value of Whole-Body Total Lesion Glycolysis at Pretreatment FDG PET/CT in Non-Small Cell Lung Cancer, Radiology, vol.264, issue.2, pp.559-66, 2012. ,
Prognostic Value of Volumetric Parameters of (18)F-FDG PET in Non- Small-Cell Lung Cancer: A Meta-Analysis, European Journal of Nuclear Medicine and Molecular Imaging, vol.42, issue.2, pp.241-51, 2015. ,
Prognostic Value of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients With Advanced-Stage Non???Small-Cell Lung Carcinoma, Journal of Clinical Oncology, vol.26, issue.9, pp.1459-64, 2008. ,
DOI : 10.1200/JCO.2007.14.3628
Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.14, issue.Suppl 1, pp.11-1945, 2016. ,
DOI : 10.1586/14737140.2016.1170596
Value of F-18-Fluorodeoxyglucose Positron Emission Tomography after Induction Therapy of Locally Advanced Bronchogenic Carcinoma', The Journal of Thoracic and Cardiovascular Surgery, pp.892-99, 2004. ,
Value of Combined Interpretation of Computed Tomography Response and Positron Emission Tomography Response for Prediction of Prognosis after Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer, Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer, vol.5, issue.4, pp.497-503, 2010. ,
Fluorine 18 Fluorodeoxyglucose PET/CT Volume-based Indices in Locally Advanced Non???Small Cell Lung Cancer: Prediction of Residual Viable Tumor after Induction Chemotherapy, Radiology, vol.272, issue.3, pp.875-84, 2014. ,
DOI : 10.1148/radiol.14132191
FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2), European Journal of Nuclear Medicine and Molecular Imaging, vol.22, issue.2, pp.1057-65, 2014. ,
DOI : 10.1007/s00259-014-2687-9
Adaptive Neoadjuvant Chemotherapy Guided by 18 F-FDG PET in Resectable Non???Small Cell Lung Cancers: The NEOSCAN Trial, Journal of Thoracic Oncology, vol.11, issue.4, pp.537-581, 2016. ,
DOI : 10.1016/j.jtho.2015.12.104
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy, Immunotherapy, vol.7, issue.9, pp.967-80, 2015. ,
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?', Cancer Immunology, pp.831-869, 2014. ,
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer, Cancer Immunology Research, vol.1, issue.6, pp.365-72, 2013. ,
NHS-IL2 Combined with Radiotherapy: Preclinical Rationale and Phase Ib Trial Results in Metastatic Non-Small Cell Lung Cancer Following First-Line Chemotherapy, Journal of Translational Medicine, pp.13-32, 2015. ,